Business Context and Reporting Period
This Form 8-K is a current report filed by Cara Therapeutics, Inc. (not Tvardi Therapeutics, Inc.) on March 27, 2014. The filing announces the company's financial results for the fourth quarter and the full year ended December 31, 2013. The specific financial data is contained in a press release furnished as Exhibit 99.1 and is not detailed within the text of this 8-K form.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not enumerated in the body of this document.
Material Changes
No material changes versus prior periods are described in the text of this filing. The document serves solely as a notification that results for the period ended December 31, 2013, have been issued.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished pursuant to Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the company undertakes no duty or obligation to publicly update or revise the information contained in the referenced press release. No specific guidance, outlook, or risk factors are detailed in this text.
Investor Verification Checklist
- Verify the correct registrant name is Cara Therapeutics, Inc., as the input metadata incorrectly listed "Tvardi Therapeutics, Inc."
- Review Exhibit 99.1 (the press release dated March 27, 2014) to obtain actual financial figures for Q4 and FY 2013.
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act and may not be incorporated by reference into other filings.